Micropulse Laser Therapy as an Integral Part of Eye Disease Management
Medicina, 2023 Ocular diseases can significantly impact vision and quality of life through pathophysiological alterations to the structure of the eye. The management of these conditions often involves a combination of pharmaceutical interventions, surgical procedures ...
Flaviu Bodea +9 more
doaj +4 more sources
Spotlight on MicroPulse Laser Trabeculoplasty in Open-Angle Glaucoma: What’s on? A Review of the Literature [PDF]
Vision, 2022 Glaucoma is the most common cause of permanent blindness in the world, caused by a progressive optic neuropathy. Patients with glaucoma are often treated with topical medicines therapy in order to reduce intra-ocular pressure (IOP).
Gloria Gambini +8 more
doaj +4 more sources
Clinical Ophthalmology, 2022 Tomas M Grippo,1 Ronald MPC de Crom,2 Michael Giovingo,3 Marc Töteberg-Harms,4 Brian A Francis,5 Brian Jerkins,6 Jacob W Brubaker,7 Nathan Radcliffe,8 Jella An,9 Robert Noecker10 1Department of Ophthalmology, Hospital Aleman, Buenos Aires, Argentina ...
Grippo TM +9 more
doaj +4 more sources
Scientific Reports, 2021 The purpose of the study was to assess both anatomic and functional outcomes between short-pulse continuous wavelength and infrared micropulse lasers in the treatment of DME.
Abdulrahman Al-Barki +7 more
doaj +2 more sources
Micropulse laser for persistent optic disc pit maculopathy. A case report
American Journal of Ophthalmology Case Reports, 2018 Purpose: Optic disc pits (ODP) are rare and congenital anomalies of the optic disc, sometimes remaining asymptomatic. However, serous macular detachment or optic disc maculopathy is the most common complication, causing significant visual deterioration ...
Carlos Andrés Valdés-Lara +4 more
doaj +2 more sources
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT [PDF]
Health Technology Assessment, 2022 Background: The National Institute for Health and Care Excellence recommends macular laser to treat diabetic macular oedema with a central retinal subfield thickness of 400 µm.
Noemi Lois +26 more
doaj +2 more sources
Comparative study between subthreshold (micropulse) laser direct application to the edematous macula versus direct application to the peripheral healthy retina in the treatment of diabetic macular edema. [PDF]
Al-Azhar International Medical Journal, 2023 Background: Subthreshold (micropulse) laser is an effective modality in the treatment of diabetic macular edema that avoids possible complications of conventional laser photocoagulation and anti-vascular endothelial growth factor. Regardless of where the
Eslam Alharif, Hamed Taha, Mohamed Rahed
doaj +1 more source
Trials, 2022 Background At present, intraocular injection of anti-VEGF (vascular endothelial growth factor) drugs has replaced traditional laser therapy as the first-line treatment for DME (diabetic macular edema). However, ranibizumab, a commonly used anti-VEGF drug,
Xuejing Mi, Xiaoya Gu, Xiaobing Yu
doaj +1 more source
A review on technology and different probes in transscleral cyclophotocoagulation
TNOA Journal of Ophthalmic Science and Research, 2022 Glaucoma is a chronic progressive optic neuropathy, characterised by retinal ganglion cell loss leading to optic nerve head changes and visual field defects.
M Salu +3 more
doaj +1 more source
Macular laser photocoagulation in the management of diabetic macular edema: Still relevant in 2020?
Taiwan Journal of Ophthalmology, 2020 Macular laser photocoagulation (MLP) is inferior to intravitreal vascular endothelial growth factor (VEGF) inhibitors in the treatment of center-involved diabetic macular edema (DME).
Marcelo Zas +4 more
doaj +1 more source